Cerity Partners LLC Genmab A/S Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Genmab A/S stock. As of the latest transaction made, Cerity Partners LLC holds 48,003 shares of GMAB stock, worth $988,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,003

Previous 41,900 14.57%

Holding current value

$988,381

Previous $1.05 Million 11.22%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.84 - $28.48 $145,495 - $173,813	6,103 Added 14.57%	48,003 $1.17 Million
Q2 2024 Aug 13, 2024	SELL	$25.13 - $30.27 $182,041 - $219,275	-7,244 Reduced 14.74%	41,900 $1.05 Million
Q1 2024 May 14, 2024	SELL	$26.43 - $32.77 $156,174 - $193,637	-5,909 Reduced 10.73%	49,144 $1.47 Million
Q4 2023 Jan 26, 2024	BUY	$27.94 - $35.44 $1.19 Million - $1.51 Million	42,661 Added 344.26%	55,053 $1.75 Million
Q3 2023 Nov 13, 2023	SELL	$35.27 - $42.24 $1.84 Million - $2.2 Million	-52,072 Reduced 80.78%	12,392 $437,000
Q2 2023 Aug 14, 2023	BUY	$37.4 - $42.94 $1,047 - $1,202	28 Added 0.04%	64,464 $2.45 Million
Q1 2023 May 11, 2023	SELL	$34.88 - $43.22 $96,896 - $120,065	-2,778 Reduced 4.13%	64,436 $2.43 Million
Q4 2022 Feb 15, 2023	BUY	$33.8 - $47.06 $36,233 - $50,448	1,072 Added 1.62%	67,214 $2.85 Million
Q3 2022 Nov 10, 2022	BUY	$31.52 - $373.61 $163,336 - $1.94 Million	5,182 Added 8.5%	66,142 $2.13 Million
Q2 2022 Aug 10, 2022	BUY	$26.83 - $38.57 $140,320 - $201,721	5,230 Added 9.38%	60,960 $1.98 Million
Q1 2022 Apr 25, 2022	SELL	$30.95 - $39.68 $350,323 - $449,137	-11,319 Reduced 16.88%	55,730 $2.02 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $270,639 - $355,520	7,545 Added 12.68%	67,049 $2.65 Million
Q3 2021 Oct 25, 2021	SELL	$41.55 - $48.72 $6,938 - $8,136	-167 Reduced 0.28%	59,504 $2.6 Million
Q2 2021 Aug 11, 2021	BUY	$32.88 - $44.57 $2,170 - $2,941	66 Added 0.11%	59,671 $2.44 Million
Q1 2021 Aug 11, 2021	BUY	$30.92 - $44.4 $247 - $355	8 Added 0.01%	59,605 $1.96 Million
Q1 2021 May 12, 2021	SELL	$30.92 - $44.4 $83,453 - $119,835	-2,699 Reduced 4.33%	59,597 $1.96 Million
Q4 2020 Feb 11, 2021	BUY	$33.66 - $40.76 $250,396 - $303,213	7,439 Added 13.56%	62,296 $2.53 Million
Q3 2020 Nov 12, 2020	BUY	$33.07 - $38.68 $1.81 Million - $2.12 Million	54,857 New	54,857 $2.01 Million
Q4 2019 Feb 14, 2020	SELL	$18.88 - $24.14 $232,979 - $297,887	-12,340 Closed	0 $0
Q3 2019 Oct 30, 2019	BUY	$18.0 - $21.38 $222,120 - $263,829	12,340 New	12,340 $250,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Genmab A/S Transaction History